Cargando…
Thyroid function in children with growth hormone (GH) deficiency during the initial phase of GH replacement therapy - clinical implications
BACKGROUND: Normal thyroid hormone secretion or appropriate L-thyroxine (L-T(4)) substitution is necessary for the optimal effect of the growth hormone (GH) administration on growth rate. The decrease of free thyroxine (FT(4)) levels at recombinant human GH (rhGH) therapy onset has been reported in...
Autores principales: | Smyczynska, Joanna, Hilczer, Maciej, Stawerska, Renata, Lewinski, Andrzej |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2858102/ https://www.ncbi.nlm.nih.gov/pubmed/20307267 http://dx.doi.org/10.1186/1756-6614-3-2 |
Ejemplares similares
-
Do IGF-I concentrations better reflect growth hormone (GH) action in children with short stature than the results of GH stimulating tests? Evidence from the simultaneous assessment of thyroid function
por: Smyczyńska, Joanna, et al.
Publicado: (2011) -
Effectiveness, economical and safety aspects of growth hormone (GH) therapy in growth promoting doses in patients with isolated GH deficiency after the attainment of near-final height. Is there a need to modify the criteria of therapy withdrawal?
por: Smyczyńska, Joanna, et al.
Publicado: (2021) -
Significance of Direct Confirmation of Growth Hormone Insensitivity for the Diagnosis of Primary IGF-I Deficiency
por: Smyczyńska, Joanna, et al.
Publicado: (2020) -
Frequency of oligosymptomatic gastrointestinal tract diseases and its relation to insulin-like growth factor I in idiopathic (non-GH-deficient) short stature children
por: Stawerska, Renata, et al.
Publicado: (2020) -
Pre-treatment growth and IGF-I deficiency as main predictors of response to growth hormone therapy in neural models
por: Smyczyńska, Urszula, et al.
Publicado: (2017)